Systemic Inflammation and Peripheral T Cell Responses Associate With Hepatic Energy Metabolism in Recent‐Onset Type 1 Diabetes
Jacqueline M. Ratter-Rieck(Deutsches Diabetes-Zentrum e.V.), GDS group, Yuliya Kupriyanova(Deutsches Diabetes-Zentrum e.V.), Alexandra Zepina(Deutsches Diabetes-Zentrum e.V.), S Trenkamp(Deutsches Diabetes-Zentrum e.V.), V Schrauwen-Hinderling(Deutsches Diabetes-Zentrum e.V.), Christian Herder(Düsseldorf University Hospital), Robert Wagner(Düsseldorf University Hospital), Agnese Petrera(Helmholtz Zentrum München), Michael Roden(Düsseldorf University Hospital), Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.)
Cited by 0
Related Papers
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
|Metabolism|2024|137
Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study
|Diabetologia|2023|59
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis
|Proceedings of the National Academy of Sciences|2025|33